Can I use the Nextera XT library prep kit on a 2kb cDNA amplicon? Just wanting to check that the tagmentation process will work ok on cDNA. I've only ever used it on gDNA for WGS.
Thanks in advance!
Thanks in advance!
-
-
Yes, currently Smart-Seq, Drop-Seq, Fludigm single cell RNA-Seq, Illumina Bio-Rad single cell and some other techniques use Nextera to prep libraries from cDNA. -
Thanks nucacidhunter. Do you think I could prep a 2kb amplicon (amplified from cDNA) using Nextera XT? Basically treating it like gDNA?
I usually run WGS with Nextera XT and MiSeq v2 reagent kit, but I've been asked to sequence a bunch of 2kb viral cDNA amplicons. Just wondering if I could use Nextera XT, or if a different prep kit would be needed.Comment
-
Generally tagmentation will work with any dsDNA. Two points to note:
1- Some sequences from both 3' and 5' end will not be sequenced because transposon requires some region to engage with DNA. It is around 30 bases.
2- Transposon have some bias which in whole genome does not make much difference but if the amplicon lacks the preference sites (it is not very restrict) some region might not get good coverage.Comment
-
Thanks - that's really helpful. I expect Illumina don't communicate precisely what their transposon sites are?
I suppose it'd just be a case of prepping a couple of amplicons to see how it goes.
Sorry to test your patience, but does tagmentation also work on eukaryotic DNA? You say it'll generally work with any dsDNA, but just checking.
Thanks again!Comment
-
I am not sure if Nextera preference site has been studied in details. It just was a precautionary note and in most experiments it does not affect final results.
Nextera works on eukaryotic DNA as well.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment